LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...

Oscar-winning actress Lupita Nyong’o is sharing about her experience of being diagnosed with uterine fibroids, using the ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

The National Biotechnology Research and Development Agency (NBRDA) has said biotechnology is more relevant than ever, ...

The Karnataka government is reportedly planning to launch a dedicated AI Mission in tandem with the Centre-led IndiaAI ...

Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.

The global biotechnology market stands poised to reach an unprecedented $5.85 trillion by 2034. The compound annual growth of 13.6% from its current $1.64 trillion valuation tells only part of the ...

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

The Health Ministry, Bandung Institute of Technology (ITB), and Del Technology Institute (IT Del) have inked a memorandum of understanding to bolster ...

Giant hogweed, an invasive species, can cause painful blisters, as well as scars and sensitivity to sunlight that can last ...

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the 'Company”), a clinical stage pharmaceutical company, today announced ...